Table 3.
Complications according to Clavien-Dindo
| Clavien-Dindo | Complication | Therapeutic management | VLNT group | VLNT + WAL group | p-value | |
|---|---|---|---|---|---|---|
| I | Seroma | Needle aspiration | Number (SD) | 5 (9.40) | 1 (2.30) | 0.107 |
| I | Hematoma | Needle aspiration/evacuation | Number (SD) | 2 (3.80) | 2 (4.50) | 0.228 |
| I | After Bleeding | Hemostasis through pressure dressing | Number (SD) | 1 (1.90) | 0 | 0.550 |
| I | Convulsive attack | Nihil | Number (SD) | 1 (1.90) | 0 | 0.550 |
| II | Erysipelas | Antibiotics | Number (SD) | 1 (1.90) | 0 | 0.550 |
| IIIa | Prolonged secretion groin | Redon’s suction drainage | Number (SD) | 0 | 1 (2.30) | 0.550 |
| IIIa | Wound healing disorder at recipient site | Dressing changes and vacuum-assisted closure therapy | Number (SD) | 2 (3.80) | 1 (2.30) | 0.230 |
| IIIa | Wound healing disorder at donor and recipient site | Dressing changes and vacuum-assisted closure therapy | Number (SD) | 0 | 1 (2.30) | 0.230 |
| IIIb | Edge necrosis | Surgical debridement | Number (SD) | 1 (1.90) | 0 | 0.141 |
| IIIb | Fat necrosis | Surgical debridement | Number (SD) | 2 (3.80) | 0 | 0.108 |
| IIIb | Partial flap loss | Surgical revision | Number (SD) | 1 (1.90) | 0 | 0.141 |
| IIIb | Total flap loss | Surgical revision | Number (SD) | 1 (1.90) | 0 | 0.141 |